In case of breast cancers, ICB is only used, either alone or in combination with chemotherapy, in the treatment of advanced TNBC and HER2+ breast cancer cases, where T cell infiltration is markedly higher compared to ER+PR+ luminal A and luminal B subtypes (151, 153). The gene discussed is ERBB2; the disease is breast carcinoma.